Item Type | Name |
Academic Article
|
Diagnosis and course of nephrogenic ascites.
|
Academic Article
|
Gastroduodenal complications of chronic NSAID therapy.
|
Academic Article
|
Infective endocarditis in drug addicts. Experiences with medical and surgical treatment.
|
Academic Article
|
Gastric radiotherapy as treatment of hereditary hemorrhagic telangiectasia.
|
Academic Article
|
Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test.
|
Academic Article
|
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection.
|
Academic Article
|
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection.
|
Academic Article
|
Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.
|
Academic Article
|
Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.
|
Academic Article
|
Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin.
|
Academic Article
|
Angiotherapy with Mallory-Weiss tear.
|
Academic Article
|
Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus.
|
Academic Article
|
Infectious esophagitis.
|
Academic Article
|
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
|
Academic Article
|
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
|
Academic Article
|
High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
|
Academic Article
|
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
|
Academic Article
|
Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
|
Academic Article
|
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
|
Academic Article
|
Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains.
|
Academic Article
|
A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage, with a comparison of heat probe and ethanol injection.
|
Academic Article
|
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?
|
Academic Article
|
A randomized comparison of dilatation alone versus dilatation plus laser in patients receiving chemotherapy and external beam radiation for esophageal carcinoma.
|
Academic Article
|
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
|
Academic Article
|
Novel therapies for Helicobacter pylori infection.
|
Academic Article
|
Gastric mucosal hydrophobicity and Helicobacter pylori: response to antimicrobial therapy.
|
Academic Article
|
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
|
Academic Article
|
Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy.
|
Academic Article
|
Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria.
|
Academic Article
|
Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial.
|
Academic Article
|
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection.
|
Academic Article
|
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
|
Academic Article
|
Diagnosis and management of Helicobacter pylori infection.
|
Academic Article
|
An objective end point for dilation improves outcome of peptic esophageal strictures: a prospective randomized trial.
|
Academic Article
|
Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori.
|
Academic Article
|
Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection.
|
Academic Article
|
Update on Helicobacter pylori research. Eradication.
|
Academic Article
|
Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
|
Academic Article
|
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea.
|
Academic Article
|
Fundic gland polyps developing during omeprazole therapy.
|
Academic Article
|
Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.
|
Academic Article
|
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.
|
Academic Article
|
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
|
Academic Article
|
Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy.
|
Academic Article
|
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.
|
Academic Article
|
Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
|
Academic Article
|
Furazolidone combination therapies for Helicobacter pylori infection in the United States.
|
Academic Article
|
Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
|
Academic Article
|
Antibiotic-resistant H. pylori infection and its treatment.
|
Academic Article
|
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
|
Academic Article
|
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
|
Academic Article
|
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border.
|
Academic Article
|
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
|
Academic Article
|
NSAIDs, Helicobacter pylori, and Pandora's Box.
|
Academic Article
|
Pathogenesis and therapy of gastric and duodenal ulcer disease.
|
Academic Article
|
One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm.
|
Academic Article
|
Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.
|
Academic Article
|
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
|
Academic Article
|
Palliative treatment of esophageal cancer: new role of endoprosthesis?
|
Academic Article
|
CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection.
|
Academic Article
|
Schatzki's ring: to cut or break an unresolved problem.
|
Academic Article
|
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States.
|
Academic Article
|
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.
|
Academic Article
|
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
|
Academic Article
|
Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin.
|
Academic Article
|
Double-blind randomized trial of quadruple sequential Helicobacter pylori eradication therapy in asymptomatic infected children in El Paso, Texas.
|
Academic Article
|
Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally.
|
Academic Article
|
The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer.
|
Academic Article
|
Helicobacter pylori eradication and its effect on iron stores: a reappraisal.
|
Academic Article
|
Treatment of Helicobacter pylori in Latin America.
|
Academic Article
|
Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer.
|
Academic Article
|
In vivo tests of natural therapy, Tibetan yogurt or fresh broccoli, for Helicobacter pylori infection.
|
Academic Article
|
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
|
Academic Article
|
Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection.
|
Academic Article
|
A report card to grade Helicobacter pylori therapy.
|
Academic Article
|
New concepts of resistance in the treatment of Helicobacter pylori infections.
|
Academic Article
|
Efficient identification and evaluation of effective Helicobacter pylori therapies.
|
Academic Article
|
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.
|
Academic Article
|
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.
|
Academic Article
|
Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage.
|
Academic Article
|
Clinical practice: diagnosis and evaluation of dyspepsia.
|
Academic Article
|
Biliary stenting in the management of large or multiple common bile duct stones.
|
Academic Article
|
Helicobacter pylori treatment in the era of increasing antibiotic resistance.
|
Academic Article
|
Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage.
|
Academic Article
|
Obscure gastrointestinal bleeding: where do we go from here?
|
Academic Article
|
Understanding and appreciating sequential therapy for Helicobacter pylori eradication.
|
Academic Article
|
Helicobacter pylori eradication therapy research: Ethical issues and description of results.
|
Academic Article
|
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study.
|
Academic Article
|
Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread.
|
Academic Article
|
Which Therapy for Helicobacter pylori Infection?
|
Academic Article
|
Empiric therapies for Helicobacter pylori infections.
|
Academic Article
|
Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days.
|
Academic Article
|
Guide regarding choice of second-line therapy to obtain a high cumulative cure rate.
|
Academic Article
|
Helicobacter pylori: tailored therapy with novel sequential quadruple therapies.
|
Academic Article
|
Treatment of steatorrhea in chronic pancreatitis.
|
Academic Article
|
Bougienage is effective therapy for most benign esophageal strictures.
|
Academic Article
|
Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
|
Academic Article
|
Hepatic adenoma: a possible complication of oral contraceptive therapy.
|
Academic Article
|
Treatment of benign esophageal strictures. Where do we go from here?
|
Academic Article
|
Clarithromycin-amoxycillin therapy for Helicobacter pylori infection.
|
Academic Article
|
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries.
|
Academic Article
|
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
|
Academic Article
|
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach.
|
Academic Article
|
Sustained increase in gastric antral epithelial cell proliferation despite cure of Helicobacter pylori infection.
|
Academic Article
|
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study.
|
Academic Article
|
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
|
Academic Article
|
Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen.
|
Academic Article
|
Factors influencing the eradication of Helicobacter pylori with triple therapy.
|
Academic Article
|
Failures in a proton pump inhibitor therapeutic substitution program: lessons learned.
|
Academic Article
|
Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy.
|
Academic Article
|
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.
|
Academic Article
|
Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.
|
Academic Article
|
Optimal therapy for Helicobacter pylori infections.
|
Academic Article
|
Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study.
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Combined Modality Therapy
|
Concept
|
Salvage Therapy
|
Concept
|
Treatment Outcome
|
Concept
|
Therapeutic Irrigation
|
Concept
|
Enzyme Replacement Therapy
|
Concept
|
Laser Therapy
|
Concept
|
Treatment Failure
|
Concept
|
Embolization, Therapeutic
|
Academic Article
|
Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China.
|
Academic Article
|
Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection.
|
Academic Article
|
Helicobacter pylori therapy demystified.
|
Academic Article
|
Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics.
|
Academic Article
|
Follow-up testing after treatment of Helicobacter pylori infections: cautions, caveats, and recommendations.
|
Academic Article
|
High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradication.
|
Academic Article
|
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
|
Academic Article
|
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.
|
Academic Article
|
Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?
|
Academic Article
|
Helicobacter pylori infection: diagnosis and treatment.
|
Academic Article
|
Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.
|
Academic Article
|
Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy.
|
Academic Article
|
Helicobacter pylori infection.
|
Academic Article
|
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.
|
Academic Article
|
Evidence-based recommendations for successful Helicobacter pylori treatment.
|
Academic Article
|
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.
|
Academic Article
|
Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance.
|
Academic Article
|
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections.
|
Academic Article
|
Lactobacillus reuteri in the treatment of Helicobacter pylori infection.
|
Academic Article
|
Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
|
Academic Article
|
Metachronous gastric cancer after successful Helicobacter pylori eradication.
|
Academic Article
|
RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.
|
Academic Article
|
Editorial: quadruple therapy for H. pylori eradication is better than triple therapy - authors' reply.
|
Academic Article
|
Roadmap for elimination of gastric cancer in Korea.
|
Academic Article
|
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.
|
Academic Article
|
Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second line regimen in the presence of levofloxacin resistance.
|
Academic Article
|
Prospective, randomized comparison of 2 methods of cold snare polypectomy for small colorectal polyps.
|
Academic Article
|
Letter: clarithromycin dose for H.?pylori therapy remains unresolved.
|
Academic Article
|
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.
|
Academic Article
|
Helicobacter pylori: New Thoughts and Practices.
|
Academic Article
|
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
|
Academic Article
|
Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.
|
Academic Article
|
Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype.
|
Academic Article
|
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
|
Academic Article
|
Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
|
Academic Article
|
Helicobacter pylori therapy: a paradigm shift.
|
Academic Article
|
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
|
Academic Article
|
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
|
Academic Article
|
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues.
|
Academic Article
|
Increasing role for modified bismuth-containing quadruple therapies for Helicobacter pylori eradication.
|
Academic Article
|
New Insight Into an Effective Treatment of Marginal Ulceration After Roux-en-Y Gastric Bypass.
|
Academic Article
|
Helicobacter pylori Therapy in the West.
|
Academic Article
|
Rescue Therapy for Helicobacter pylori.
|
Academic Article
|
Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.
|
Academic Article
|
Reply.
|
Academic Article
|
Helicobacter pylori infection and antibiotic resistance: a WHO high priority?
|
Academic Article
|
Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.
|
Academic Article
|
It is time to rethink H. pylori therapy.
|
Academic Article
|
Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best.
|
Academic Article
|
Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?
|
Academic Article
|
Mechanical colon cleansing for screening colonoscopy: A randomized controlled trial.
|
Academic Article
|
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
|
Academic Article
|
Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.
|
Academic Article
|
Helicobacter pylori management in ASEAN: The Bangkok consensus report.
|
Academic Article
|
Update on the Use of Vonoprazan: A Competitive Acid Blocker.
|
Academic Article
|
Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency.
|
Academic Article
|
Lessons From Using Culture-Guided Treatment After Referral for Multiple Treatment Failures for Helicobacter pylori Infection.
|
Academic Article
|
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.
|
Academic Article
|
Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer.
|
Academic Article
|
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial.
|
Academic Article
|
Enzyme therapy for functional bowel disease-like post-prandial distress.
|
Academic Article
|
Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.
|
Academic Article
|
Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model.
|
Academic Article
|
Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
|
Academic Article
|
Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.
|
Grant
|
The Role of Mycobacteria in Crohn's Disease
|
Grant
|
CAMPYLOBACTER PYLORIDIS IN GASTRODUODENAL DISEASE
|
Academic Article
|
The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal.
|
Academic Article
|
Current and Future Treatment of Helicobacter pylori Infections.
|
Academic Article
|
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment.
|
Concept
|
Enzyme Therapy
|
Academic Article
|
High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial.
|
Academic Article
|
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial.
|
Academic Article
|
Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment-authors' reply.
|
Academic Article
|
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen,?or?Ibuprofen.
|
Academic Article
|
Rational Use of Pancreatic Enzymes for Pancreatic Insufficiency and Pancreatic Pain.
|
Academic Article
|
Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera? or Lactobacillus reuteri for treatment na?ve or for retreatment of Helicobacter pylori. Two randomized pilot studies.
|
Academic Article
|
Susceptibility-guided therapy for Helicobacter pylori infection treatment failures.
|
Academic Article
|
14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment.
|
Academic Article
|
High-flow nasal cannula oxygen therapy obscures severe respiration depression, providing an illusion of safety.
|
Academic Article
|
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis.
|
Academic Article
|
Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial.
|
Academic Article
|
Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
|
Academic Article
|
Is there a role for sequential in sequential anti-H. pylori therapy?
|
Academic Article
|
The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trials.
|
Academic Article
|
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy.
|
Academic Article
|
Recent Developments Pertaining to H. pylori Infection.
|
Academic Article
|
Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial.
|
Academic Article
|
Transitioning of Helicobacter pylori Therapy from Trial and Error to Antimicrobial Stewardship.
|
Academic Article
|
Pathogenesis and treatment of rotavirus diarrhea.
|
Academic Article
|
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study.
|
Academic Article
|
Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship.
|
Academic Article
|
Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.
|
Academic Article
|
Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy.
|
Academic Article
|
Helicobacter pylori diagnosis and therapy in the era of antimicrobial stewardship.
|
Academic Article
|
Diagnosis and Treatment of Helicobacter pylori Infection.
|
Academic Article
|
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta-analysis and critical analysis.
|
Academic Article
|
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities.
|
Academic Article
|
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study.
|
Academic Article
|
Response to: a true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication.
|
Academic Article
|
Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates.
|
Academic Article
|
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.
|
Academic Article
|
It Is Time for a Paradigm Shift in Design, Execution, and Publishing of Comparative Helicobacter pylori Treatment Trials.
|
Academic Article
|
Eradicating Helicobacter pylori via 13C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
|
Academic Article
|
Controversies regarding management of Helicobacter pylori infections.
|
Academic Article
|
Pilot studies of vonoprazan-containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan.
|
Academic Article
|
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran.
|